PAI-1, His, Human
| $300.00 | |
| Z05731-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $300.00 | |
| Z05731-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Species | Human | ||||
| Protein Construction |
|
||||
| Purity | > 95% as determined by BisTris PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Biological Activity | Measured by its ability to inhibit uPA cleavage of a peptide substrate, NcarbobenzyloxyGlyGlyArg7amido4methylcoumarin (ZGGRAMC). The IC50 value is < 35 nM. Test result meets the standard. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 43.86 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 45-55 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22 μm filtered solution in 50mM NaAC, 0.1M NaCl, 100mM L-arginine (pH 5.5). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in 50mM NaAC, 0.1M NaCl, 100mM L-arginine (pH 5.5). | ||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
The purity of PAI-1, His, Human is greater than 95% as determined by SEC-HPLC. »
PAI-1, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | PAI-1 (plasminogen activator inhibitor-1) is a member of plasminogen cascade with an inhibitory role in plasmin activation. PAI-1 is an important regulator of the fibrinolytic process and levels of this antifibrinolytic protein are elevated in diabetes and insulin resistant states. |
| Synonyms | PAI; PAI-1; Serpin E1; SERPINE1; PAI1; PLANH1 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.